PMID- 10504507 OWN - NLM STAT- MEDLINE DCOM- 19991202 LR - 20131121 IS - 0085-2538 (Print) IS - 0085-2538 (Linking) VI - 56 IP - 4 DP - 1999 Oct TI - Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. PG - 1551-9 AB - BACKGROUND: It is widely recognized that living-related donor (LRD) renal allografts have a higher overall graft survival than cadaver donor transplants. We tested the hypothesis that part of this is attributable to LRD kidneys being obtained under optimal conditions from healthy donors, whereas cadaveric kidneys may have experienced injury as a result of inflammatory events around the time of brain death. METHODS: We have performed a comparative immunohistochemical analysis of pretransplant donor biopsies from cadaveric (N = 65) and LRD (N = 29) kidneys to determine any differences that may predispose them to subsequent damage. Cryostat sections were stained with antibodies to leukocytes, adhesion molecules, and human leukocyte antigen (HLA)-DR antigens, and the expression was assessed semiquantitatively. RESULTS: High levels of endothelial E-selectin and proximal tubular expression of HLA-DR antigens, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 were detected in biopsies from cadaveric kidneys, whereas expression of these markers was markedly reduced in LRD kidneys. High levels of tubular antigen expression were significantly associated with traumatic death, prolonged ventilation, and episodes of infection in cadaver donors. Furthermore, the expression of pretransplant tubular antigens in cadaver donor kidneys was significantly associated with early acute rejection following transplantation, suggesting that such kidneys are predisposed to subsequent immune-mediated attack following transplantation. CONCLUSIONS: These results may explain, in part, the superior outcome of LRD allografts compared with cadaver renal allografts. FAU - Koo, D D AU - Koo DD AD - Nuffield Department of Surgery and Oxford Transplant Center, University of Oxford, John Radcliffe Hospital, England, United Kingdom. FAU - Welsh, K I AU - Welsh KI FAU - McLaren, A J AU - McLaren AJ FAU - Roake, J A AU - Roake JA FAU - Morris, P J AU - Morris PJ FAU - Fuggle, S V AU - Fuggle SV LA - eng PT - Clinical Trial PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Kidney Int JT - Kidney international JID - 0323470 RN - 0 (Antibodies, Monoclonal) RN - 0 (E-Selectin) RN - 0 (HLA-DR Antigens) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (P-Selectin) RN - 0 (Renal Agents) RN - 0 (Vascular Cell Adhesion Molecule-1) RN - 126547-89-5 (Intercellular Adhesion Molecule-1) RN - ENR1LLB0FP (Deamino Arginine Vasopressin) SB - IM MH - Adult MH - Antibodies, Monoclonal MH - Biopsy MH - Cadaver MH - Deamino Arginine Vasopressin/administration & dosage MH - E-Selectin/analysis MH - Endothelium/chemistry/immunology/metabolism MH - Female MH - Graft Survival/drug effects/*immunology MH - HLA-DR Antigens/analysis/metabolism MH - Histocompatibility Antigens Class II/*analysis/immunology/metabolism MH - Humans MH - Intensive Care Units MH - Intercellular Adhesion Molecule-1/analysis/metabolism MH - Kidney Transplantation/*immunology MH - Kidney Tubules, Proximal/chemistry/immunology/pathology MH - *Living Donors MH - Male MH - Middle Aged MH - P-Selectin/analysis MH - Renal Agents/administration & dosage MH - *Transplantation Immunology MH - Transplantation, Homologous MH - Vascular Cell Adhesion Molecule-1/analysis/metabolism EDAT- 1999/10/03 00:00 MHDA- 1999/10/03 00:01 CRDT- 1999/10/03 00:00 PHST- 1999/10/03 00:00 [pubmed] PHST- 1999/10/03 00:01 [medline] PHST- 1999/10/03 00:00 [entrez] AID - S0085-2538(15)46464-6 [pii] AID - 10.1046/j.1523-1755.1999.00657.x [doi] PST - ppublish SO - Kidney Int. 1999 Oct;56(4):1551-9. doi: 10.1046/j.1523-1755.1999.00657.x.